Sign up for free insights newsletter
68

Cathay Biotech Inc

688065SHG

Need professional-grade analysis? Visit stockanalysis.com

CN¥49.00
-13.41%
End of day
Market Cap

$37.41B

P/E Ratio

56.37

Employees

1,735

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.230.14-0.03
Calmar-0.330.17-0.05
Sharpe-0.170.10-0.02
Omega1.001.061.03
Martin-0.770.33-0.16
Ulcer9.0210.659.93

Cathay Biotech Inc (688065) Price Performance

Cathay Biotech Inc (688065) trades on SHG in CNY. The company is classified in the Basic Materials sector under the Chemicals industry. The stock currently trades at CNY49.00, down 13.41% from the previous close.

Over the past year, 688065 has traded between a low of CNY44.43 and a high of CNY62.24. The stock has gained 1.1% over this period. It is currently 21.3% below its 52-week high.

Cathay Biotech Inc has a market capitalization of $37.41B, with a price-to-earnings ratio of 56.37.

About Cathay Biotech Inc

Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing. The company's products are used in textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, engineering materials, and other industries. It exports its products. The company was incorporated in 2000 and is headquartered in Shanghai, China.

Company Info

Industry
Chemicals
Exchange
SHG
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$3.30B
EBITDA
$951.01M
Profit Margin
17.17%
EPS (TTM)
0.92
Book Value
24.98

Technical Indicators

52 Week High
CN¥64.50
52 Week Low
CN¥42.71
50 Day MA
CN¥55.27
200 Day MA
CN¥50.93
Beta
0.71

Valuation

Trailing P/E
56.37
Forward P/E
N/A
Price/Sales
11.35
Price/Book
2.15
Enterprise Value
$29.10B